Sort
78,016 grants matching “breast cancer”
Prevention of Heart Failure induced by Doxorubicin with Early Administration of Dexrazoxane
$727,686Hui-Ming Chang · Univ Of Arkansas For Med Scis · R01 · FY2021 · HL
ROLE OF DKK3 IN TRIPLE-NEGATIVE BREAST CANCER TUMOR PROGRESSION AND RESISTANCE TO THERAPY
$727,496The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2022 · Defense Health Agency
Mechanisms of fibrosis and lymphatic dysfunction in post-surgical lymphedema
$727,473Babak J Mehrara · Sloan-Kettering Inst Can Research · R01 · FY2015 · HL
IGF::OT::IGF R&D-A PHASE I TRIAL OF THE SAFETY AND IMMUNOGENICITY OF A DNA PLASMID BASED VACCINE (WOKVAC) ENCODING EPITOPES DERIVED FROM THREE BREAST CANCER ANTIGENS (IGFBP-2, HER2, AND IGF-IR) IN PAT
$727,469Howard Bailey · University Of Wisconsin-Madison · N01 · FY2015 · CA
Surgical Treament for Early State Breast Cancer
$727,455University Of Michigan At Ann Arbor · R01 · FY2002 · CA
Developing a personalized breast cancer screening tool using sequential mammograms
$727,410Juhun Lee · University Of Pittsburgh At Pittsburgh · R37 · FY2025 · CA
A phase I/II combination immunotherapy clinical trial: mesothelin-targeted chimeric antigen receptor T cells and checkpoint blockade agent in pleural mesothelioma
$727,344Prasad S. Adusumilli · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
A phase I/II combination immunotherapy clinical trial: mesothelin-targeted chimeric antigen receptor T cells and checkpoint blockade agent in pleural mesothelioma
$727,344Prasad S. Adusumilli · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Duluth Community Clinical Oncology Program
$727,154Daniel A Nikcevich · Duluth Clinic, Ltd. · U10 · FY2010 · CA
Biomarker Approach to Screening for the early detection of HPV-related Oropharyngeal Cancer (BASH OPC)
$727,078Anna R Giuliano · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2023 · DE
Metropolitan New York Registry of Breast Cancer Families
$726,941Mary Beth Terry · Columbia University Health Sciences · U01 · FY2006 · CA
Breaking the Obesity-Cancer Link: New Targets and Strategies
$726,930Stephen D Hursting · Univ Of North Carolina Chapel Hill · R35 · FY2019 · CA
Career Development in Pediatric and Medical Oncology
$726,905Soheil Meshinchi · Fred Hutchinson Cancer Center · K12 · FY2022 · CA
Human Variants
$726,845Joann B Sweasy · University Of Vermont & St Agric College · P01 · FY2011 · CA
Radiation-induced translational control of gene expression
$726,840Philip Tofilon · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
CRITICAL ROLE OF PROTEIN CONDENSATION IN BREAST CANCER
$726,738Rector & Visitors Of The University Of Virginia · · FY2020 · Defense Health Agency
Effect and Mechanism of Acupuncture for Cancer-related Cognitive Impairment (ENHANCE)
$726,619Jun J Mao · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
REGULATION OF SENESCENCE BY P38 MAP KINASE IN ERBB-2-INDUCED BREAST CANCER.
$726,451The Medical University Of South Carolina · · FY2008 · Department of Defense
(3 of 3) MMC, VICC & TSU: Partners in Eliminating Cancer Disparities
$726,440Margaret M Whalen · Tennessee State University · U54 · FY2022 · CA
Alleviation of chemotherapy-induced cardiovascular toxicity
$726,408Yanbo Fan · University Of Cincinnati · R01 · FY2024 · HL
Combined Digital X-Ray, Optical, and Ultrasound Breast Imaging
$726,385Paul L Carson · University Of Michigan At Ann Arbor · R01 · FY2012 · CA
Prevention of Heart Failure induced by Doxorubicin with Early Administration of Dexrazoxane
$726,166Hui-Ming Chang · Univ Of Arkansas For Med Scis · R01 · FY2022 · HL
DOTA-based pre-targeting of alpha emitters
$726,157Sarah Marie Cheal · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
BREAST CANCER IMMUNOTHERAPY WITH ANTI-TIM-3
$726,110H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc. · · FY2020 · Defense Health Agency
Molecular Biology of the Metastatic Phenotype
$725,886Patricia Schriver Steeg · Division Of Clinical Sciences - Nci · ZIA · FY2009 · CA